A Combinatorial Strategy for Tageting Papillary Thyroid Carcinoma with MEK Inhibitor and SHP2 Inhibitor

Jingtai Zhi(Tianjin First Center Hospital), Ming Gao(Chinese Academy of Forestry)

Research Square

October 8, 2020

10.21203/rs.3.rs-86062/v1

Cited by 0

Related Papers

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma

|Cancer Biology and Medicine|2017|124

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma

|Cell Death and Disease|2021|100

Antitumor effects of anlotinib in thyroid cancer

|Endocrine Related Cancer|2018|92

METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer

|Cell Death and Differentiation|2023|78

S100A4/NF-κB axis mediates the anticancer effect of epigallocatechin-3-gallate in platinum-resistant ovarian cancer

|iScience|2024|16